Down-regulation of NADPH-diaphorase (nitric oxide synthase) may account for the pharmacological activities of Cu(II)2 (3,5-diisopropylsalicylate)4.
Baquial
J G
JG
Sorenson
J R
JR
D015536:Down-Regulation; D007004:Hypoglycemic Agents / Q000494:pharmacology; D009252:NADPH Dehydrogenase / Q000378:metabolism*; D019001:Nitric Oxide Synthase / Q000378:metabolism*; D012459:Salicylates / Q000494:pharmacology*
D007004:Hypoglycemic Agents; D012459:Salicylates; C030865:copper bis(3,5-diisopropylsalicylate); D019001:Nitric Oxide Synthase; D009252:NADPH Dehydrogenase